Apolipoprotein and lipid abnormalities in chronic liver failure

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 11, 1997, Pages 1287-1290

  Sposito A C ^a   Vinagre, C G ^a   Pandullo, F L ^a   Mies, S ^a   Raia, S ^a   Ramires, J A F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apolipoprotein A; Apolipoprotein B; Chronic liver disease; HDL cholesterol; LCAT; Lipid metabolism; Liver failure; VLDL cholesterol

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD; FEMALE; HUMAN; LIVER FAILURE; MALE; MIDDLE AGED;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LIVER FAILURE; MALE; MIDDLE AGED;

EID: 0031263244     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-879X1997001100004     Document Type: Article

References (15)

1. Fujii S, Koga S, Shono T, Yamamoto K & Ibayashi H (1981). Serum apoprotein A-I and A-II levels in liver diseases and cholestasis. Clinica Chimica Acta, 115: 321-331.
2. Rubies-Prat J, Masdeu S, Nubiola AR, Chacon P, Holguera C & Masana L (1982). High-density lipoprotein cholesterol and phospholipids, and apoprotein A in serum of patients with liver disease. Clinical Chemistry, 28: 525-527.
3. Koga S, Yamamoto K & Ibayashi H (1984). Alterations in levels of apolipoprotein C-III and C-II/C-III ratios in patients with liver disease. Gastroenterologia Japonica, 19: 65-71.
4. Perales J, Angel Lasuncion M, Cano A, Martin-Scapa MA, Maties M & Herrera E (1994). Changes in the lipid profile in chronic hepatopathies. Medical Clinics of North America, 102: 364-368.
5. Day RC, Harry DS, Owen JS, Foo AY & McIntyre N (1979). Lecithin-cholesterol acyltransferase and lipoprotein abnormalities of parenchymal liver disease. Clinical Science, 56: 575-583.
6. Simon JB & Scheig R (1970). Serum cholesterol esterification in liver disease. New England Journal of Medicine, 283: 841-846.
7. Roschlau P (1975). 9th International Congress of Clinical Chemistry, Toronto, Abstract No. 1. Tunder P. Annals of Clinical Biochemistry, 1969, 6: 24. Apud: Merck (Rio de Janeiro). Cholesterol Chod-Pap: Método colorimétrico enzimático (Artigo No. 172, 626-bula).
8. Bercolo G & David H (1973). Quantitative determination of serial triglycerides by the use of enzymes. Clinical Chemistry, 19: 476-482.
9. Warnick GR, Cheung MC & Albers JJ (1979). Comparison of current methods for high density lipoprotein cholesterol quantification. Clinical Chemistry, 25: 596-604.
10. Friedwald WT, Levy RI & Fredrickson DS (1972). Estimation of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clinical Chemistry, 18: 499-502.
11. Albers I, Hartmann H, Bircher J & Creutzfeldt W (1989). Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scandinavian Journal of Gastroenterology, 24: 269-276.
12. Seidel D, Alaupovic P, Furman RH & McConathy WJ (1970). A lipoprotein characterizing obstructive jaundice. Journal of Clinical Investigation, 49: 2396-2407.
13. Vergani C, Trovato G, Delu A, Pietrogrande M & Dioguardi N (1978). Serum total lipids, lipoprotein cholesterol and apolipoprotein A in acute viral hepatitis and chronic liver disease. Journal of Clinical Pathology, 31: 772-778.
14. Agorastos J, Boswell C, Harry DS & McIntyre N (1976). Plasma lipoproteins in liver disease. Biochemical Society Transactions, 4: 593-596.
15. Eisenberg S (1984). High density lipoprotein metabolism. Journal of Lipid Research, 25: 1017-1054.